Can a quick genetic test save critically ill newborns?
NCT ID NCT04848090
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether whole genome sequencing can help doctors diagnose genetic disorders faster in newborns admitted to intensive care. Researchers will compare the time to diagnosis and care costs for 400 infants who receive this advanced genetic test versus standard testing. The goal is to see if quicker answers lead to better medical decisions and outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- whole genome sequencing (a detailed genetic test)
- What this could lead to
- If successful, this could show that rapid genetic testing helps doctors diagnose seriously ill newborns faster and improve their care.
- What could go wrong
- This is an observational study, not a treatment trial. It may not prove that faster diagnosis leads to better outcomes, and results may not apply to all hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENETIC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive global registry aims to unlock secrets of rett syndrome
- Biobank aims to unlock genetic secrets of rare diseases
- Common antibiotic could tame rare calcium disorder
- New study maps developmental milestones in babies with rare genetic conditions
- Genetic detective study aims to solve medical mysteries for 1,000 undiagnosed patients
- 12,000-Person study aims to unlock genetic secrets of rare diseases